Internal Medicine, Medical Oncology · Richmond, VA
NPI
1659461291
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1250 E Marshall St, Internal Medicine
Richmond, VA, 23298
Phone (804) 828-7999
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
765 services
Medicare patients, 2024
353
Average age 74
Drug cost, 2024
$2.1M
929 prescriptions
Company payments, 2025
$155
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary H Hackney was code 99213 (office e&m - established), 289 times for 209 patients. In total Mary H Hackney billed 765 services in 19 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 289 | 209 | $47.56 | $14K |
| 99214 Office E&M - Established | Office | 187 | 101 | $70.93 | $13K |
| 99213 Office E&M - Established | Facility | 68 | 47 | $48.61 | $3,305 |
| 99214 Office E&M - Established | Facility | 59 | 35 | $70.19 | $4,141 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 46 | 27 | $12.61 | $580 |
By year: 2022 $52K for 810 services; 2023 $52K for 778 services; 2024 $43K for 765 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mary H Hackney prescribed most often to Medicare patients was Anastrozole, with 317 prescriptions and refills. In total Mary H Hackney wrote 929 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 317 | 829 | 101 | $6,665 |
| Letrozole Generic | 133 | 330 | 39 | $4,008 |
| Exemestane Generic | 74 | 152 | 23 | $11K |
| Kisqali Ribociclib Succinate | 61 | 61 | Under 11 | $996K |
| Tamoxifen Citrate Generic | 48 | 130 | 16 | $1,098 |
| Ibrance Palbociclib | 32 | 32 | Under 11 | $473K |
| Ondansetron Hcl Generic | 21 | 21 | 14 | $1,371 |
| Eliquis Apixaban | 14 | 16 | Under 11 | $9,057 |
| Tramadol Hcl Generic | 13 | 13 | Under 11 | $65.36 |
| Tukysa Tucatinib | 12 | 12 | Under 11 | $180K |
| Verzenio Abemaciclib | 12 | 12 | Under 11 | $164K |
| Everolimus Generic | 11 | 11 | Under 11 | $11K |
| Prochlorperazine Maleate Generic | 11 | 11 | Under 11 | $119 |
Brand drugs: 162 claims; generic drugs: 767 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mary H Hackney $155 ($155 in general payments such as food, travel and fees) from 2 companies. The largest payer was Novo Nordisk Inc with $124.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.